Pharma Industry News

Sanofi refuses to refund Philippines for used Dengvaxia, saying to do so would imply the shot is ineffective

Written by David Miller

Sanofi Pasteur has turned down the Philippine government's request to refund it for used Dengvaxia shots worth over $30 million, saying that agreeing to do so would imply that the vaccine is ineffective.Original Article

About the author

David Miller

a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.

[mwai_chat window="true" fullscreen="true"]